Independent Director · Benitec Biopharma Inc. (BNTC)

Edward F. Smith — Benitec Biopharma Director Compensation (2025)

Fiscal year 2025 director compensation for Edward F. Smith at Benitec Biopharma Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed October 14, 2025 (DEF 14A). Open the filing on EDGAR.

What they were paid

Benitec Biopharma Director Compensation Table · the one fiscal year held
In US dollars, as Benitec Biopharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$56,500$0$368,410$0$424,910

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Benitec Biopharma Inc. DEF 14A filed October 14, 2025, accession 0001193125-25-239131, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

Benitec Biopharma pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit · Compensation · Nominating/Governance

The rest of the Benitec Biopharma board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Dr. Jerel BanksDirector$0
J. Kevin BuchiIndependent Director$432,410
Kishen MehtaIndependent Director$368,410
Megan BostonDirector$0
Peter FrancisIndependent Director$426,993

The full Benitec Biopharma compensation record

free company brief

This page is one director within Benitec Biopharma's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy